PBS approves new hepatitis C medicines

Written By Unknown on Monday, 18 February 2013 | 17:27



MORE than 130,000 people will advantage from new and extended medicine subsidies by a Pharmaceutical Benefits Scheme (PBS).


Among a listings announced on Tuesday by Minister for Health Tanya Plibersek are groundbreaking treatments for ongoing hepatitis C.

The supervision will yield some-more than $220 million over 5 years to finance a drugs boceprevir (Victrelis) and telaprevir (Incivo), that could double a heal rate and digest a diagnosis by 6 months, Ms Plibersek pronounced in Sydney.

As one of a many ordinarily reported notifiable diseases in Australia, hepatitis C represents a poignant open health problem.

In many cases, a pathogen can swell into life-threatening conditions such as liver disaster and liver cancer.

It was estimated in 2011 that during least

Read full article: http://www.thesun.co.uk/sol/homepage/news/4800731/June-Steenkamp-demands-answers.html


Source:
http://www.news.ezonearticle.com/2013/02/18/pbs-approves-new-hepatitis-c-medicines-2/

0 comments:

Post a Comment